Results 21 to 30 of about 843,680 (375)
GB virus C viremia and anti-E2 antibody response among hemodialysis patients in Gorgan, Iran [PDF]
, 2014 Background: GB Virus C is a blood-borne virus and a member of Flaviviridae, like hepatitis C that is distributed globally and puts hemodialysis patients at high risk of developing liver disease.
Bazouri, M. +7 more
core +1 more source
Hepatitis C-vírus-fertőzés kiújulása májátültetés után. Mi változott az elmúlt 10 évben? [PDF]
, 2014 Introduction: Management of hepatitis C virus recurrence is a challenge after liver transplantation. Aim: The aim of the authors was to analyse the outcome of liver transplantation performed in hepatitis C virus positive patients during the past ten ...
Doros, Attila +19 more
core +1 more source
Hepatitis C virus biology [PDF]
Cell Death & Differentiation, 2003 Hepatitis C virus infection represents a major problem of public health with around 350 millions of chronically infected individuals worldwide. The frequent evolution towards severe liver disease and cancer are the main features of HCV chronic infection.
GIANNINI, CARLO, Brechot C.
openaire +4 more sources
Microbiologia Medica, 2016 Background and aims: Hepatitis C virus (HCV) represents a major worldwide public health problem requiring global action for the diagnosis, treatment and prevention of this infection.
Sara Salvetti +2 more
doaj +1 more source
Adaptive Learning Expert System for Diagnosis and Management of Viral Hepatitis [PDF]
International journal of artificial intelligence and applications,
2019, Volume 10, Number 2, 2019 Viral hepatitis is the regularly found health problem throughout the world among other easily transmitted diseases, such as tuberculosis, human immune virus, malaria and so on. Among all hepatitis viruses, the uppermost numbers of deaths are result from the long-lasting hepatitis C infection or long-lasting hepatitis B. In order to develop this system,
arxiv +1 more source
An update on hepatitis C virus [PDF]
Clinical Medicine, 2015 Chronic hepatitis caused by hepatitis C virus infection is one of the leading causes of liver cirrhosis and hepatocellular carcinoma globally. Over the last few years, there have been significant advances in our understanding of the immunopathogenesis of this infection, as well as revolutionary developments in the therapeutic armamentarium.
Klenerman, P, Fitzmaurice, K
openaire +4 more sources
A Discrete Simulation Optimization Approach Towards Calibration of an Agent-based Simulation Model of Hepatitis C Virus Transmission [PDF]
, 2021 This study demonstrates the implementation of the stochastic ruler discrete simulation optimization method for calibrating an agent-based model (ABM) developed to simulate hepatitis C virus (HCV) transmission. The ABM simulates HCV transmission between agents interacting in multiple environments relevant for HCV transmission in the Indian context.
arxiv +1 more source
Hepatitis C virus and autoimmunity [PDF]
Autoimmunity Highlights, 2010 Hepatitis C virus infection is associated with several extrahepatic manifestations. About 60% of patients infected with HCV develop at least one extrahepatic manifestation. The majority of these diseases seem to be triggered through autoimmune mechanisms, such as autoantibody production, autoreactive T cells and complex autoimmune mechanisms leading to
N Sepp, Barbara C. Böckle
openaire +2 more sources
Hepatitis C virus and hepatocarcinogenesis
Clinical and Molecular Hepatology, 2012 Hepatitis C virus (HCV) is an RNA virus that is unable to integrate into the host genome. However, its proteins interact with various host proteins and induce host responses. The oncogenic process of HCV infection is slow and insidious and probably requires multiple steps of genetic and epigenetic alterations, the activation of cellular oncogenes, the ...
Jeong, Soung Won +2 more
openaire +5 more sources
Case Reports in Gastroenterology, 2016 Following interferon-based therapy for chronic hepatitis C, the negativity of hepatitis C virus RNA is essential to achieve viral clearance at the end of treatment.
Akira Sato +5 more
doaj +1 more source